Evidence map›Paper›PMID 36743439›Full record

ArticleFrontiers in neuroinformatics2022

2.5D and 3D segmentation of brain metastases with deep learning on multinational MRI data.

Jon André Ottesen, Darvin Yi, Elizabeth Tong, Michael Iv, Anna Latysheva, Cathrine Saxhaug, Kari Dolven Jacobsen, Åslaug Helland, Kyrre Eeg Emblem, Daniel L Rubin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Jon André OttesenCRAI, Division of Radiology and Nuclear Medicine, Department of Physics and Computational Radiology, Oslo University Hospital, Oslo, Norway.
Darvin YiDepartment of Ophthalmology, University of Illinois, Chicago, IL, United States.
Elizabeth TongDepartment of Radiology, Stanford University, Stanford, CA, United States.
Michael IvDepartment of Radiology, Stanford University, Stanford, CA, United States.
Anna LatyshevaDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Cathrine SaxhaugDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Kari Dolven JacobsenDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Åslaug HellandDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Kyrre Eeg EmblemDivision of Radiology and Nuclear Medicine, Department of Physics and Computational Radiology, Oslo University Hospital, Oslo, Norway.
Daniel L RubinDepartment of Biomedical Data Science, Stanford University, Stanford, CA, United States.
Atle BjørnerudCRAI, Division of Radiology and Nuclear Medicine, Department of Physics and Computational Radiology, Oslo University Hospital, Oslo, Norway.
Greg ZaharchukDepartment of Radiology, Stanford University, Stanford, CA, United States.
Endre GrøvikDepartment of Radiology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway.
Oslo University Hospital · NOStanford University · USNorwegian University of Science and Technology · NOUniversity of Illinois Chicago · USUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Management of patients with brain metastases is often based on manual lesion detection and segmentation by an expert reader. This is a time- and labor-intensive process, and to that end, this work proposes an end-to-end deep learning segmentation network for a varying number of available MRI available sequences. Methods: We adapt and evaluate a 2.5D and a 3D convolution neural network trained and tested on a retrospective multinational study from two independent centers, in addition, nnU-Net was adapted as a comparative benchmark. Segmentation and detection performance was evaluated by: (1) the dice similarity coefficient, (2) a per-metastases and the average detection sensitivity, and (3) the number of false positives. Results: The 2.5D and 3D models achieved similar results, albeit the 2.5D model had better detection rate, whereas the 3D model had fewer false positive predictions, and nnU-Net had fewest false positives, but with the lowest detection rate. On MRI data from center 1, the 2.5D, 3D, and nnU-Net detected 79%, 71%, and 65% of all metastases; had an average per patient sensitivity of 0.88, 0.84, and 0.76; and had on average 6.2, 3.2, and 1.7 false positive predictions per patient, respectively. For center 2, the 2.5D, 3D, and nnU-Net detected 88%, 86%, and 78% of all metastases; had an average per patient sensitivity of 0.92, 0.91, and 0.85; and had on average 1.0, 0.4, and 0.1 false positive predictions per patient, respectively. Discussion/Conclusion: Our results show that deep learning can yield highly accurate segmentations of brain metastases with few false positives in multinational data, but the accuracy degrades for metastases with an area smaller than 0.4 cm

Indexed as

2.5D3Dbrain metastasesdeep learningMRIsegmentation

Identifiers

PMID36743439
PMCPMC9889663
OpenAlexW4317395573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.